NCT01723241

Phase 1 Study of XAF5 Gel Applied to Skin of Healthy Volunteers

A Randomized, Placebo-controlled, Double-blind, Multiple-ascending-dose Study to Assess the Safety and Tolerability of XAF5 Gel Applied to the Skin of Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Topokine Therapeutics, Inc. · Industry
• Sex: All
• Age: 25 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This is a study to assess the safety, tolerability, and pharmacokinetics of XAF5 Gel when applied to the skin of healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	XAF5, concentration A
DRUG	XAF5, concentration B
DRUG	XAF5, concentration C
DRUG	Placebo

Timeline

• Start date: 2012-11-01
• Primary completion: 2013-04-01
• Completion: 2013-04-01
• First posted: 2012-11-07
• Last updated: 2016-01-12